세계의 경성 내시경 시장 : 유형별, 임상 용도별, 용도별, 최종사용자별, 지역별 - 예측(-2030년)

The global rigid endoscopes market is projected to reach USD 2.32 billion by 2030, growing from USD 1.83 billion in 2025, at a CAGR of 4.9% during the forecast period. The growth of the rigid endoscopes market is driven by the rising prevalence of chronic diseases, increasing demand for minimally invasive surgeries, and advancements in imaging and optics technology.

Opportunities exist in emerging markets due to the expansion of healthcare infrastructure, increasing procedural volumes, and rising medical tourism, which enable the adoption of advanced endoscopic solutions. However, market growth faces challenges from risks of viral infections, lack of proper sterilization and reprocessing, and high procedural costs, which may limit widespread adoption, particularly in resource-constrained regions.

The arthroscopes segment is expected to grow at the fastest rate in the rigid endoscopes market during the forecast period.

By type, the rigid endoscopes market is segmented into laparoscopes, urology endoscopes, gynecology endoscopes, arthroscopes, cytoscopes, neuroendoscopes, and other rigid endoscopes. Among these, the urology endoscopes segment accounted for the second-largest market share in 2024, owing to the increasing prevalence of musculoskeletal disorders, particularly among the aging global population. According to the WHO, the number of people aged 60 and above is projected to rise from 1.1 billion in 2023 to 1.4 billion by 2030, creating a substantial patient pool at higher risk for joint-related conditions. Age-related degenerative diseases such as osteoarthritis are becoming more common, with the CDC reporting that arthritis prevalence increases sharply with age-from 3.6% in adults aged 18-34 to 53.9% in individuals 75 and older-driving demand for minimally invasive orthopedic interventions. Arthroscopy offers a precise, less invasive solution for diagnosing and treating joint injuries, reducing recovery time, and improving surgical outcomes, which enhances patient preference and procedural adoption. Additionally, advancements in high-definition imaging, improved surgical instruments, and growing awareness among orthopedic specialists are further accelerating the adoption of arthroscopes, positioning this segment for the fastest growth within the rigid endoscopes market.

The surgical usage segment accounted for the largest share of the rigid endoscopes market in 2024.

By clinical usage, the rigid endoscopes market has been divided into diagnostic & surgical usage. Among these, the surgical usage segment accounted for the largest share of the market in 2024. This is due to the increasing adoption of minimally invasive procedures across multiple specialties, including laparoscopy, arthroscopy, urology, gynecology, and ENT. Rigid endoscopes serve as the core platform for these interventions, offering superior optical clarity, high-definition and 4K visualization, and robust, autoclavable designs that integrate seamlessly with surgical instruments and operating room workflows. The growing preference for minimally invasive surgeries is driven by benefits such as shorter hospital stays, reduced post-operative complications, faster patient recovery, and enhanced clinical outcomes, which directly influence procedure volumes and market demand for rigid scopes.

Asia Pacific is projected to grow at the highest rate in the rigid endoscopes market during the forecast period.

The global rigid endoscopes market is segmented into five major regions: North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. Among these, the Asia Pacific region is projected to grow at the highest rate during the forecast period. This is primarily due to the development of healthcare infrastructure, increasing healthcare expenditure, and rising awareness of early disease detection across populous nations such as China and India. These countries are investing heavily to enhance diagnostic and surgical capabilities, particularly to manage the rising cases of chronic diseases, such as cancer, pulmonary, and urological disorders. Japan's well-established healthcare system with universal insurance coverage ensures wide accessibility to advanced endoscopic procedures. Moreover, increasing medical tourism, favorable government initiatives, and the rising adoption of minimally invasive technologies are accelerating market penetration, making the Asia Pacific a high-growth region in the global rigid endoscopes market.

A breakdown of the primary participants referred to for this report is provided below:

• By Company Type: Tier 1 -40%, Tier 2 -30%, and Tier 3 -30%
• By Designation: C-level -50%, Director level -30%, and Others -20%
• By Region: North America -30%, Europe - 25%, Asia Pacific -20%, Latin America -15%, and Middle East & Africa -10%

Notes:

Companies are classified into tiers based on their total revenue. The tiers are as follows: Tier 1 = >USD 10.0 billion, tier 2 = USD 1.0 billion to USD 10.0 billion, and tier 3 = <USD 1.0 billion

C-level primaries include CEOs, CFOs, COOs, and VPs.

Others include sales managers, marketing managers, business development managers, product managers, distributors, and suppliers.

The players operating in the rigid endoscopes market include Olympus Corporation (Japan), KARL STORZ SE & Co. KG (Germany), Stryker (US), Medtronic (Ireland), Smith+Nephew (UK), B Braun SE (Germany), CONMED Corporation (US), Arthrex Inc. (US), Nipro (Japan), FUJIFILM Corporation (Japan), Hologic, Inc. (US), Shangrao WS Medtech Co., Ltd (China), Henke-Sass, Wolf (Germany), RUDOLF Medical GmbH + Co. KG (Germany), EndoMed Systems GmbH (Germany), Teleflex Incorporated (US), Integrated Endoscopy (US), NeoScope, Inc. (US), Ecleris (US), Nanchang WOEK Medical Technology Co., Ltd (China), Richard Wolf GmbH. (Germany), ATMOS MedizinTechnik GmbH & Co. KG (Germany), Kashmir Surgical Works. (India), Optomic (Spain), and HIPP ENDOSKOP SERVICE GMBH (Germany)

Research Coverage

This report examines the rigid endoscopes market by type, application, end user, and region. The report also examines key factors (including drivers, restraints, opportunities, and challenges) influencing market growth and provides an in-depth analysis of the competitive landscape for market leaders. Furthermore, the report analyzes micro markets with respect to their individual growth trends. It forecasts the revenue of the market segments with respect to five major regions (and the respective countries in these regions).

Reasons to Buy the Report

The report will enable established firms as well as smaller entrants to gauge the market's pulse, which, in turn, will help them gain a larger market share. Firms purchasing the report could use one or a combination of the following strategies to strengthen their market presence.

This report provides insights into the following pointers:

• Analysis of key drivers (increasing investments, funds, and grants by government and other organizations, growing focus of hospitals to expand endoscopic units, increasing preference for minimally invasive surgeries, rising need for endoscopy to diagnose & treat target diseases), restraints (high overhead costs of endoscopy procedures, increased risk of getting infections during endoscopic procedures), opportunities (rapidly developing healthcare sector in emerging countries), challenges (increasing number of product recalls, lack of sterilization & reprocessing)
• Market Penetration: Complete knowledge of the spectrum of products presented by the major companies in the rigid endoscopes market
• Product Development/Innovation: Comprehensive understanding of the forthcoming trends, research and development initiatives, and product launches within the rigid endoscopes market
• Market Development: Complete knowledge about profitable developing regions
• Market Diversification: Exhaustive knowledge of new goods, expanding geographies, and current changes in the rigid endoscopes industry helps to diversify the market
• Competitive Assessment: In-depth assessment of market share, growth strategies, and product offerings of leading players like Olympus Corporation (Japan), Karl Storz SE & CO. KG (Germany), Stryker (US), Nipro (Japan), EndoMed Systems GmbH (Germany), Richard Wolf GmbH. (Germany), Ambu A/S (Denmark), Smith+Nephew (UK), and others.

TABLE OF CONTENTS

1 INTRODUCTION

• 1.1 STUDY OBJECTIVES
• 1.2 MARKET DEFINITION
• 1.3 STUDY SCOPE
  • 1.3.1 MARKET SEGMENTATION & REGIONAL SCOPE
  • 1.3.2 INCLUSIONS & EXCLUSIONS
  • 1.3.3 YEARS CONSIDERED
  • 1.3.4 CURRENCY CONSIDERED
• 1.4 STAKEHOLDERS

2 RESEARCH METHODOLOGY

• 2.1 RESEARCH DATA
  • 2.1.1 SECONDARY DATA
    • 2.1.1.1 Key objectives of secondary research
    • 2.1.1.2 Key data from secondary sources
  • 2.1.2 PRIMARY DATA
    • 2.1.2.1 Key primary sources
    • 2.1.2.2 Key objectives of primary research
    • 2.1.2.3 Key industry insights
    • 2.1.2.4 Key data from primary sources
• 2.2 MARKET SIZE ESTIMATION
  • 2.2.1 SUPPLY-SIDE ANALYSIS (REVENUE SHARE ANALYSIS)
  • 2.2.2 TOP-DOWN APPROACH
  • 2.2.3 COMPANY PRESENTATIONS & PRIMARY INTERVIEWS
  • 2.2.4 DEMAND-SIDE ANALYSIS (USING RIGID ENDOSCOPES)
• 2.3 DATA TRIANGULATION
• 2.4 MARKET RANKING ANALYSIS
• 2.5 STUDY ASSUMPTIONS
• 2.6 RESEARCH LIMITATIONS
  • 2.6.1 METHODOLOGY-RELATED LIMITATIONS
  • 2.6.2 SCOPE-RELATED LIMITATIONS
• 2.7 RISK ASSESSMENT

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

• 4.1 RIGID ENDOSCOPES MARKET OVERVIEW
• 4.2 NORTH AMERICA: RIGID ENDOSCOPES MARKET, BY END USER AND COUNTRY
• 4.3 RIGID ENDOSCOPES MARKET: GEOGRAPHIC MIX
• 4.4 RIGID ENDOSCOPES MARKET: EMERGING VS. DEVELOPED ECONOMIES

5 MARKET OVERVIEW

• 5.1 INTRODUCTION
• 5.2 MARKET DYNAMICS
  • 5.2.1 DRIVERS
    • 5.2.1.1 Growing preference for minimally invasive surgeries
    • 5.2.1.2 Increasing burden of chronic and lifestyle-related diseases
  • 5.2.2 RESTRAINTS
    • 5.2.2.1 High overhead costs
    • 5.2.2.2 Risk of viral infections during endoscopic procedures
  • 5.2.3 OPPORTUNITIES
    • 5.2.3.1 Rapidly developing healthcare sector in emerging economies
  • 5.2.4 CHALLENGES
    • 5.2.4.1 Product recalls
    • 5.2.4.2 Lack of sterilization and reprocessing
• 5.3 INDUSTRY TRENDS
  • 5.3.1 ADVANCED IMAGING TECHNOLOGIES
  • 5.3.2 MINIATURIZATION AND ULTRA-SLIM DESIGNS
• 5.4 TRENDS/DISRUPTIONS IMPACTING CUSTOMER'S BUSINESS
• 5.5 PRICING ANALYSIS
  • 5.5.1 AVERAGE SELLING PRICE TREND A OF RIGID ENDOSCOPES, BY KEY PLAYER, 2022-2024
  • 5.5.2 AVERAGE PRICING TREND OF RIGID ENDOSCOPES, BY REGION, 2022-2024
• 5.6 VALUE CHAIN ANALYSIS
• 5.7 SUPPLY CHAIN ANALYSIS
• 5.8 ECOSYSTEM ANALYSIS
• 5.9 INVESTMENT & FUNDING SCENARIO
• 5.10 TECHNOLOGY ANALYSIS
  • 5.10.1 KEY TECHNOLOGIES
    • 5.10.1.1 Illumination technology
  • 5.10.2 COMPLEMENTARY TECHNOLOGIES
    • 5.10.2.1 Surgical visualization
  • 5.10.3 ADJACENT TECHNOLOGIES
    • 5.10.3.1 3D endoscopic visualization
• 5.11 TRADE ANALYSIS
  • 5.11.1 IMPORT DATA FOR HS CODE 9018, 2019-2024
  • 5.11.2 EXPORT DATA FOR HS CODE 9018, 2019-2024
• 5.12 REGULATORY ANALYSIS
  • 5.12.1 REGULATORY LANDSCAPE
    • 5.12.1.1 North America
      • 5.12.1.1.1 US
      • 5.12.1.1.2 Canada
    • 5.12.1.2 Europe
    • 5.12.1.3 Asia Pacific
      • 5.12.1.3.1 Japan
      • 5.12.1.3.2 China
      • 5.12.1.3.3 India
    • 5.12.1.4 Latin America
    • 5.12.1.5 Middle East & Africa
  • 5.12.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
• 5.13 PATENT ANALYSIS
  • 5.13.1 PATENT PUBLICATION TREND
  • 5.13.2 JURISDICTION AND TOP APPLICANT ANALYSIS
  • 5.13.3 LIST OF PATENTS
• 5.14 KEY CONFERENCES & EVENTS, 2025-2026
• 5.15 PORTER'S FIVE FORCES ANALYSIS
  • 5.15.1 THREAT OF NEW ENTRANTS
  • 5.15.2 THREAT OF SUBSTITUTES
  • 5.15.3 BARGAINING POWER OF BUYERS
  • 5.15.4 BARGAINING POWER OF SUPPLIERS
  • 5.15.5 INTENSITY OF COMPETITIVE RIVALRY
• 5.16 KEY STAKEHOLDERS & BUYING CRITERIA
  • 5.16.1 KEY STAKEHOLDERS IN BUYING PROCESS
  • 5.16.2 BUYING CRITERIA
• 5.17 ADJACENT MARKET ANALYSIS
  • 5.17.1 FLEXIBLE ENDOSCOPES MARKET
• 5.18 UNMET NEEDS/END-USER EXPECTATIONS
• 5.19 IMPACT OF AI/GEN AI ON RIGID ENDOSCOPES MARKET
  • 5.19.1 INTRODUCTION
  • 5.19.2 AI USE CASES
  • 5.19.3 KEY COMPANIES IMPLEMENTING AI
  • 5.19.4 FUTURE OF GENERATIVE AI ON RIGID ENDOSCOPES MARKET
• 5.20 IMPACT OF 2025 US TARIFFS ON RIGID ENDOSCOPES MARKET
  • 5.20.1 INTRODUCTION
  • 5.20.2 KEY TARIFF RATES
  • 5.20.3 PRICE IMPACT ANALYSIS
  • 5.20.4 IMPACT ON REGION
    • 5.20.4.1 North America
    • 5.20.4.2 Europe
    • 5.20.4.3 Asia Pacific
  • 5.20.5 IMPACT ON END-USE INDUSTRY

6 RIGID ENDOSCOPES MARKET, BY TYPE

• 6.1 INTRODUCTION
• 6.2 LAPAROSCOPES
  • 6.2.1 RISING GLOBAL PREVALENCE OF GYNECOLOGICAL AND CANCER CONDITIONS TO PROPEL MARKET GROWTH
• 6.3 UROLOGY ENDOSCOPES
  • 6.3.1 RISING UROLOGICAL DISORDERS AND TECHNOLOGICAL ADVANCES TO DRIVE GROWTH IN UROLOGY ENDOSCOPES SEGMENT
• 6.4 GYNECOLOGY ENDOSCOPES
  • 6.4.1 INCREASING PREVALENCE OF GYNECOLOGICAL CANCERS AMONG WOMEN TO AID MARKET GROWTH
• 6.5 ARTHROSCOPES
  • 6.5.1 RISING GERIATRIC POPULATION AND GROWING INCIDENCE OF ORTHOPEDIC DISEASES TO BOOST MARKET GROWTH
• 6.6 CYSTOSCOPES
  • 6.6.1 RISING BLADDER CANCER CASES AND MINIMALLY INVASIVE BENEFITS TO DRIVE CYSTOSCOPES MARKET GROWTH
• 6.7 NEUROENDOSCOPES
  • 6.7.1 RISING NEUROLOGICAL DISORDERS AND INVESTMENTS IN ADVANCED CARE TO DRIVE MARKET GROWTH
• 6.8 OTHER RIGID ENDOSCOPES

7 RIGID ENDOSCOPES MARKET, BY CLINICAL USAGE

• 7.1 INTRODUCTION
• 7.2 SURGICAL USAGE
  • 7.2.1 RISING ADOPTION OF MINIMALLY INVASIVE SURGERIES TO DRIVE SEGMENTAL GROWTH
• 7.3 DIAGNOSTIC USAGE
  • 7.3.1 GROWING DEMAND FOR OFFICE-BASED ENT, GYNECOLOGY, AND UROLOGY PROCEDURES TO ACCELERATE GROWTH

8 RIGID ENDOSCOPES MARKET, BY APPLICATION

• 8.1 INTRODUCTION
• 8.2 LAPAROSCOPY
  • 8.2.1 BROAD CLINICAL APPLICABILITY AND STRONG PROCEDURAL DEMAND ACROSS DIAGNOSTIC AND THERAPEUTIC INTERVENTIONS TO AID GROWTH
• 8.3 UROLOGY ENDOSCOPY
  • 8.3.1 RISING PREVALENCE OF URINARY TRACT DISEASES AND CANCERS TO FUEL MARKET
• 8.4 ARTHROSCOPY
  • 8.4.1 INCREASING PREVALENCE OF ARTHRITIS AMONG AGING POPULATION TO SPUR GROWTH
• 8.5 NEUROENDOSCOPY
  • 8.5.1 FAVORABLE GOVERNMENT AND PRIVATE SECTOR POLICIES TO SUPPORT ADOPTION OF NEUROENDOSCOPES
• 8.6 OTHER APPLICATIONS

9 RIGID ENDOSCOPES MARKET, BY END USER

• 9.1 INTRODUCTION
• 9.2 HOSPITALS
  • 9.2.1 ROBUST SURGICAL INFRASTRUCTURE AND LARGE PATIENT BASE TO FOSTER GROWTH
• 9.3 AMBULATORY SURGERY CENTERS
  • 9.3.1 GROWING PREFERENCE FOR OUTPATIENT SURGERIES AND TECHNOLOGICAL ADVANCEMENTS TO DRIVE MARKET
• 9.4 CLINICS
  • 9.4.1 RISING ADOPTION OF OUTPATIENT DIAGNOSTICS AND DECENTRALIZED HEALTHCARE TO AID GROWTH
• 9.5 OTHER END USERS

10 RIGID ENDOSCOPES MARKET, BY REGION

• 10.1 INTRODUCTION
• 10.2 NORTH AMERICA
  • 10.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA
  • 10.2.2 US
    • 10.2.2.1 US to dominate North American rigid endoscopes market during forecast period
  • 10.2.3 CANADA
    • 10.2.3.1 Rising chronic disease prevalence among aging population to drive market
• 10.3 EUROPE
  • 10.3.1 MACROECONOMIC OUTLOOK FOR EUROPE
  • 10.3.2 GERMANY
    • 10.3.2.1 Germany to dominate European rigid endoscopes market
  • 10.3.3 UK
    • 10.3.3.1 Increased aging population, high cancer prevalence, and strong healthcare infrastructure to drive market growth
  • 10.3.4 FRANCE
    • 10.3.4.1 Increase in health expenditure and high prevalence of cancer to stimulate market growth
  • 10.3.5 ITALY
    • 10.3.5.1 Increasing prevalence of chronic diseases to boost adoption
  • 10.3.6 SPAIN
    • 10.3.6.1 Rising aging population to drive market growth
  • 10.3.7 REST OF EUROPE
• 10.4 ASIA PACIFIC
  • 10.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
  • 10.4.2 CHINA
    • 10.4.2.1 China to dominate Asia Pacific rigid endoscopes market during forecast period
  • 10.4.3 JAPAN
    • 10.4.3.1 Increasing chronic disease prevalence and rising geriatric population to drive growth
  • 10.4.4 INDIA
    • 10.4.4.1 Rising osteoarthritis and cancer prevalence to drive market growth
  • 10.4.5 AUSTRALIA
    • 10.4.5.1 Advancing healthcare infrastructure to support rigid endoscopes adoption in Australia
  • 10.4.6 SOUTH KOREA
    • 10.4.6.1 Super-aged society and high disease prevalence to drive growth in South Korean market
  • 10.4.7 REST OF ASIA PACIFIC
• 10.5 LATIN AMERICA
  • 10.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA
  • 10.5.2 BRAZIL
    • 10.5.2.1 Brazil to account for largest share of Latin American market
  • 10.5.3 MEXICO
    • 10.5.3.1 Increasing minimally invasive procedures to support rigid endoscopes adoption
  • 10.5.4 REST OF LATIN AMERICA
• 10.6 MIDDLE EAST & AFRICA
  • 10.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA
  • 10.6.2 GCC COUNTRIES
    • 10.6.2.1 High healthcare investments and hospital expansions to drive market growth
  • 10.6.3 REST OF MIDDLE EAST & AFRICA

11 COMPETITIVE LANDSCAPE

• 11.1 INTRODUCTION
• 11.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
  • 11.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN RIGID ENDOSCOPES MARKET
• 11.3 REVENUE ANALYSIS, 2020-2024
• 11.4 MARKET SHARE ANALYSIS, 2024
• 11.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024
  • 11.5.1 STARS
  • 11.5.2 EMERGING LEADERS
  • 11.5.3 PERVASIVE PLAYERS
  • 11.5.4 PARTICIPANTS
  • 11.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2024
    • 11.5.5.1 Company footprint
    • 11.5.5.2 Region footprint
    • 11.5.5.3 Type footprint
    • 11.5.5.4 Application footprint
    • 11.5.5.5 End-user footprint
• 11.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024
  • 11.6.1 PROGRESSIVE COMPANIES
  • 11.6.2 RESPONSIVE COMPANIES
  • 11.6.3 DYNAMIC COMPANIES
  • 11.6.4 STARTING BLOCKS
  • 11.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024
    • 11.6.5.1 Detailed list of key startups/SMEs
    • 11.6.5.2 Competitive benchmarking of key startups/SMEs
• 11.7 COMPANY VALUATION & FINANCIAL METRICS
  • 11.7.1 FINANCIAL METRICS
  • 11.7.2 COMPANY VALUATION
• 11.8 BRAND/PRODUCT COMPARISON
• 11.9 COMPETITIVE SCENARIO
  • 11.9.1 PRODUCT LAUNCHES
  • 11.9.2 DEALS

12 COMPANY PROFILES

• 12.1 KEY PLAYERS
  • 12.1.1 OLYMPUS CORPORATION
    • 12.1.1.1 Business overview
    • 12.1.1.2 Products offered
    • 12.1.1.3 Recent developments
      • 12.1.1.3.1 Deals
    • 12.1.1.4 MnM view
      • 12.1.1.4.1 Right to win
      • 12.1.1.4.2 Strategic choices
      • 12.1.1.4.3 Weaknesses & competitive threats
  • 12.1.2 KARL STORZ SE & CO. KG
    • 12.1.2.1 Business overview
    • 12.1.2.2 Products offered
    • 12.1.2.3 Recent developments
      • 12.1.2.3.1 Product launches
      • 12.1.2.3.2 Deals
    • 12.1.2.4 MnM view
      • 12.1.2.4.1 Right to win
      • 12.1.2.4.2 Strategic choices
      • 12.1.2.4.3 Weaknesses & competitive threats
  • 12.1.3 STRYKER
    • 12.1.3.1 Business overview
    • 12.1.3.2 Products offered
    • 12.1.3.3 MnM view
      • 12.1.3.3.1 Right to win
      • 12.1.3.3.2 Strategic choices
      • 12.1.3.3.3 Weaknesses & competitive threats
  • 12.1.4 SMITH+NEPHEW
    • 12.1.4.1 Business overview
    • 12.1.4.2 Products offered
    • 12.1.4.3 MnM view
      • 12.1.4.3.1 Right to win
      • 12.1.4.3.2 Strategic choices
      • 12.1.4.3.3 Weaknesses & competitive threats
  • 12.1.5 B. BRAUN SE
    • 12.1.5.1 Business overview
    • 12.1.5.2 Products offered
    • 12.1.5.3 MnM view
      • 12.1.5.3.1 Right to win
      • 12.1.5.3.2 Strategic choices
      • 12.1.5.3.3 Weaknesses & competitive threat
  • 12.1.6 MEDTRONIC
    • 12.1.6.1 Business overview
    • 12.1.6.2 Products offered
    • 12.1.6.3 Recent developments
      • 12.1.6.3.1 Deals
  • 12.1.7 NIPRO
    • 12.1.7.1 Business overview
    • 12.1.7.2 Products offered
  • 12.1.8 RICHARD WOLF GMBH
    • 12.1.8.1 Business overview
    • 12.1.8.2 Products offered
    • 12.1.8.3 Recent developments
      • 12.1.8.3.1 Deals
  • 12.1.9 CONMED CORPORATION
    • 12.1.9.1 Business overview
    • 12.1.9.2 Products offered
  • 12.1.10 ARTHREX, INC.
    • 12.1.10.1 Business overview
    • 12.1.10.2 Products offered
• 12.2 OTHER PLAYERS
  • 12.2.1 FUJIFILM CORPORATION
  • 12.2.2 HOLOGIC, INC.
  • 12.2.3 SHANGRAO WS MEDTECH CO., LTD.
  • 12.2.4 ATMOS MEDIZINTECHNIK GMBH & CO. KG
  • 12.2.5 HENKE-SASS WOLF
  • 12.2.6 RUDOLF MEDICAL GMBH + CO. KG
  • 12.2.7 ENDOMED SYSTEMS GMBH
  • 12.2.8 TELEFLEX INCORPORATED
  • 12.2.9 INTEGRATED ENDOSCOPY
  • 12.2.10 NEOSCOPE INC.
  • 12.2.11 ECLERIS
  • 12.2.12 NANCHANG WOEK MEDICAL TECHNOLOGY CO., LTD
  • 12.2.13 KASHMIR SURGICAL WORKS
  • 12.2.14 OPTOMIC
  • 12.2.15 HIPP ENDOSKOP SERVICE GMBH

13 APPENDIX

• 13.1 DISCUSSION GUIDE
• 13.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
• 13.3 CUSTOMIZATION OPTIONS
• 13.4 RELATED REPORTS
• 13.5 AUTHOR DETAILS